12-49557497-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_012284.3(KCNH3):c.2796C>T(p.Ser932Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00169 in 1,611,532 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0088 ( 17 hom., cov: 32)
Exomes 𝑓: 0.00094 ( 18 hom. )
Consequence
KCNH3
NM_012284.3 synonymous
NM_012284.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.118
Genes affected
KCNH3 (HGNC:6252): (potassium voltage-gated channel subfamily H member 3) The protein encoded by this gene is a voltage-gated potassium channel alpha subunit predominantly expressed in the forebrain. Studies in mice have found that cognitive function increases when this gene is knocked out. In humans, the encoded protein has been shown to be capable of binding glycoprotein 120 of the human immunodeficiency virus type 1 (HIV-1) envelope. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2015]
MCRS1 (HGNC:6960): (microspherule protein 1) Enables RNA binding activity and telomerase inhibitor activity. Involved in histone H4 acetylation; negative regulation of DNA metabolic process; and positive regulation of protein localization to nucleolus. Located in cytoplasm; nucleolus; and nucleoplasm. Part of Ino80 complex; MLL1 complex; and histone acetyltransferase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BP6
Variant 12-49557497-C-T is Benign according to our data. Variant chr12-49557497-C-T is described in ClinVar as [Benign]. Clinvar id is 735166.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.118 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00883 (1345/152338) while in subpopulation AFR AF = 0.0303 (1259/41576). AF 95% confidence interval is 0.0289. There are 17 homozygotes in GnomAd4. There are 670 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 1345 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH3 | NM_012284.3 | c.2796C>T | p.Ser932Ser | synonymous_variant | Exon 15 of 15 | ENST00000257981.7 | NP_036416.1 | |
KCNH3 | NM_001314030.2 | c.2616C>T | p.Ser872Ser | synonymous_variant | Exon 15 of 15 | NP_001300959.1 | ||
KCNH3 | XM_011538085.3 | c.2829C>T | p.Ser943Ser | synonymous_variant | Exon 15 of 15 | XP_011536387.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00880 AC: 1340AN: 152220Hom.: 17 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
1340
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00257 AC: 637AN: 247758 AF XY: 0.00198 show subpopulations
GnomAD2 exomes
AF:
AC:
637
AN:
247758
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000940 AC: 1372AN: 1459194Hom.: 18 Cov.: 33 AF XY: 0.000851 AC XY: 618AN XY: 726040 show subpopulations
GnomAD4 exome
AF:
AC:
1372
AN:
1459194
Hom.:
Cov.:
33
AF XY:
AC XY:
618
AN XY:
726040
Gnomad4 AFR exome
AF:
AC:
1051
AN:
33474
Gnomad4 AMR exome
AF:
AC:
116
AN:
44694
Gnomad4 ASJ exome
AF:
AC:
3
AN:
26104
Gnomad4 EAS exome
AF:
AC:
0
AN:
39696
Gnomad4 SAS exome
AF:
AC:
8
AN:
86228
Gnomad4 FIN exome
AF:
AC:
0
AN:
51056
Gnomad4 NFE exome
AF:
AC:
55
AN:
1111840
Gnomad4 Remaining exome
AF:
AC:
127
AN:
60340
Heterozygous variant carriers
0
83
166
250
333
416
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00883 AC: 1345AN: 152338Hom.: 17 Cov.: 32 AF XY: 0.00899 AC XY: 670AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
1345
AN:
152338
Hom.:
Cov.:
32
AF XY:
AC XY:
670
AN XY:
74494
Gnomad4 AFR
AF:
AC:
0.0302819
AN:
0.0302819
Gnomad4 AMR
AF:
AC:
0.00418082
AN:
0.00418082
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000117612
AN:
0.000117612
Gnomad4 OTH
AF:
AC:
0.00661626
AN:
0.00661626
Heterozygous variant carriers
0
68
135
203
270
338
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
4
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 10, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at